Oral Anticoagulation in Atrial Fibrillation: Are the Problems Solved?

Basit Öğe Kaydı
dc.contributor.authorDoğan, Umuttan
dc.date.accessioned2020-03-26T18:04:46Z
dc.date.available2020-03-26T18:04:46Z
dc.date.issued2010
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractThe prevalence of atrial fibrillation (AF) is high and it is expected to increase in the near future (1). AF is a strong independent risk factor for ischemic stroke and systemic arterial embolisation (2). Oral anticoagulation (OAC) has been shown to decrease the risk of stroke. In a meta-analysis of 6 randomized trials including 2900 participants, the estimated relative risk reduction is reported as 64% (3). Despite the evident benefits, OAC is underused even in high-risk AF patients (4, 5). The study by Elezi et al. (6) provides an interesting retrospective analysis of the prescription of OACs in patients with AF in a single tertiary centre in Kosovo. The main finding is the low percentage of OAC use in patients with AF when compared with the previous studies. It is reported that only less than 1/3 of patients with primary or secondary diagnosis of AF were discharged on anticoagulation therapy. Elder age, normal left atrial size, and preserved ejection fraction were the independent predictors of underprescription of anticoagulants.en_US
dc.identifier.citationDoğan, U., (2010). Oral Anticoagulation in Atrial Fibrillation: Are the Problems Solved?. Anadolu Kardiyoloji Dergisi-the Anatolian Journal of Cardiology, (10), 41-42. Doi: 10.5152/akd.2010.009
dc.identifier.endpage42en_US
dc.identifier.issn1302-8723en_US
dc.identifier.pmid20150003en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage41en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/25135
dc.identifier.volume10en_US
dc.identifier.wosWOS:000275102800009en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorDoğan, Umuttan
dc.language.isoenen_US
dc.publisherAves Yayıncılıken_US
dc.relation.ispartofAnadolu Kardiyoloji Dergisi-the Anatolian Journal of Cardiologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.titleOral Anticoagulation in Atrial Fibrillation: Are the Problems Solved?en_US
dc.typeEditorialen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
5135.pdf
Boyut:
79.39 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Kardiyoloji/Makale Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu